Research News

Join WhatsApp Channel 

Crack GPAT — Prepare for GPAT Online
  • The Forgotten Half of Diabetic Kidney Disease Finally Gets Its Own Trial and the Results Are Positive
    25 March 2026

    The Forgotten Half of Diabetic Kidney Disease Finally Gets Its Own Trial and the Results Are Positive

    A phase 3 clinical trial has found that finerenone, a nonsteroidal mineralocorticoid receptor antagonist, produces a significantly greater reduction in a key marker of kidney damage compared to placebo in adults with Type 1 diabetes and chronic kidney disease (CKD). The results were published on March 5, 2026 in the New England Journal of Medicine.

  • 24 March 2026
    India's Drug Regulator Gives Conditional Green Light to Zydus's First Human Trial for Chikungunya Vaccine
    A key advisory body to Indias top drug regulator has approved the first human trial of a homegrown chikungunya vaccine developed by Ahmedabad-based Zydus Lifesciences, but not without strings attached.
  • 2 March 2026
    Study Links Faulty Dopamine Packaging to Parkinson’s Progression
    New research from Ludwig-Maximilians-Universität München (LMU) reveals that improper handling of the neurotransmitter dopamine within brain cells may play a critical role in worsening symptoms of Parkinson’s disease. The discovery provides fresh insights into how the disease damages neurons and points toward potential new treatment strategies.
  • 2 March 2026
    New Study Shows Single Dose of Non-Prescribed Adderall Can Sharply Raise Heart Rate and Blood Pressure
    A new study by researchers at the Mayo Clinic has found that a single 25 mg dose of Adderall, when taken without a prescription, can cause significant increases in both heart rate and blood pressure in healthy young adults. The findings raise important questions about the cardiovascular effects of using this stimulant medication outside of medical supervision.
  • 21 February 2026
    New Blood Cancer Treatment Gets US Approval

    The U.S. Food and Drug Administration (FDA) has approved a new cancer treatment combining acalabrutinib (Calquence) and venetoclax for adults with chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL). This decision makes it the first all-oral, fixed-duration therapy available for patients who have not had prior treatment.

  • 17 February 2026
    ICMR Study Shows Shorter Oral Regimens for Drug-Resistant TB Are Cost-Effective for India’s Health System

    A recent study led by the Indian Council of Medical Research (ICMR) has found that shorter, all-oral treatment regimens for multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) could deliver better health outcomes at lower costs compared to longer traditional therapies in India.

  • 13 February 2026
    Vegan Diet May Cut Insulin Needs in Type 1 Diabetes
    A new study published in BMC Nutrition suggests that a low-fat vegan diet may significantly reduce daily insulin requirements for people living with type 1 diabetes potentially lowering treatment costs as well.
  • 10 February 2026
    Hidden Cellular Switch Linked to Dangerous Plaque Rupture in Heart Disease
    Scientists have uncovered a previously hidden molecular trigger inside artery walls that may explain why some atherosclerotic plaques suddenly become dangerous, raising the risk of heart attacks and strokes.
  • 9 February 2026
    Oxygen-Boosted Microneedle Patch Shows Promise for More Effective Psoriasis Treatment

    Researchers have developed an innovative oxygen-boosted microneedle patch that significantly improves drug delivery and photodynamic therapy (PDT) for psoriasis, a chronic inflammatory skin disease that affects millions worldwide.

    The study, published in Acta Pharmaceutica Sinica B, describes a dual-section microneedle (MN) patch designed to overcome two major challenges in psoriasis treatment: poor drug penetration through thickened skin and reduced efficacy of PDT caused by low oxygen levels in inflamed lesions.

  • 9 February 2026
    Wearable Bioelectronics Pave the Way for Future Personal Health Monitoring

    Advances in soft and sustainable wearable bioelectronics are set to transform personal health monitoring and digital healthcare, according to a new Perspective article published in BIO Integration. Researchers highlight how skin-like wearable systems can continuously track health signals during daily life, moving care beyond occasional hospital visits.

Subscribe to Research News